Extracellular Biotechnology

Tissue Regeneration and Aging

Regenerative capacity of organs and tissues decreases with age and first signs of diminished resilience of elderly as compared to young individuals are observed as early as at the age of 45 to 50 after traumatic injuries. Besides several other factors, cellular senescence has been identified as a key driver of aging, age-associated diseases and thus also of diminished resilience. Indeed, eliminating senescent cells in various pre-clinical models of age-associated diseases including osteoarthritis or osteoporosis, but also in cartilage or bone regeneration after traumatic injuries leads to later onset or improvement of the specific conditions.

In order to understand how senescent cells that accumulate within organisms with age negatively impact on organ and tissue function and regeneration, we focus on function of miRNAs (Brenner et al., 2021; Terlecki-Zaniewicz et al., 2019) and proteins differentially regulated in senescent and stressed cells, in tissue culture models (Weinmuellner et al., 2017; Weinmüllner et al., 2020) and their impact on tissue regeneration and organismal aging (Heissenberger et al., 2020, 2019; Schosserer et al., 2015), which also allows for identifying novel senolytic targets and therapeutics. In addition, the pro-inflammatory activity of senescent cells via its senescence associated secretory phenotype (SASP) is considered a prominent driver of the aging process and inhibitor of sufficiently boosting pro-regenerative activity of the endogenous repair mechanisms. Therefore, we focus on SASP factors including lipids (Narzt et al., 2020; Pils et al., 2021) and circulating miRNAs as biomarkers for senescent cell loads in organisms or as diagnostics in age-associated diseases as well as on the pro-inflammatory SASP (Grillari et al., 2020; Hackl et al., 2015; Heilmeier et al., 2022; Morsiani et al., 2021) as a therapeutic target. We are specifically interested in developing extracellular vesicles of MSCs into potential therapeutic strategies for tissue regeneration in young and elderly individuals as a platform technology (Gimona et al., 2021; Vogt et al., 2021, 2018) that will be tested in cooperation with all groups of LBI Trauma, especially in the context of wound healing, as well as in bone, cartilage and neuroregeneration.

Vascular Biology

In most higher organisms, vessels play a fundamental role. They transport blood from the heart throughout the body and drain tissue fluid back into the blood circulation. The cells that line up the inner side of these vessels are called endothelial cells. In the human body they weigh approximately one kilogram and if all vessels are laid end-to-end together they could encompass the earth twice.

The group of Wolfgang Holnthoner focuses on basic functions of endothelial cells in the formation and growth of blood and lymphatic vessels. In tissue regeneration new vessels are expected to sprout so that organs can be supplied with oxygen and nutrients. Further research emphasis is put on:

  • Isolation of endothelial cells and their progenitor cells (EPC) from peripheral blood and fat tissue
  • Co-cultures of endothelial cells and mesenchymal stem cells as tools for vascularization for tissue engineering
  • The role of endothelial cells in blood coagulation
  • The role of extracellular vesicles such as microparticles and exosomes in vascular biology
  • The influence of purinergic signaling on endothelial sprouting

The aim is to develop vascularization strategies that can be used in a clinical setting. Central for that is the characterization of artificial vascular structures. Furthermore, the regeneration of existing blood and lymphatic vessels represents a focus of the research in the endothelial cell group.

a.

Nanoparticle-based Therapies

The major research focus is the development of methods for quantitative analysis of biological systems at the nanoscale. Our group has long-time experience in single molecule fluorescence microscopy, force microscopy as well as 2D/3D nanolithography. By precisely localising and measuring the dynamics of biomolecules and determining molecular interactions, we seek to understand their function in model systems as well as in living cells. We are currently engaged in method development for the characterisation and understanding of physical properties of individual cells, nanobioparticles or lipids and proteins. Another important aspect of our work is the application of our research to the development of device technologies and image processing tools.

Selected Publications

Lushchak O, Schosserer M, Grillari J. Senopathies-Diseases Associated with Cellular Senescence (2023). Biomolecules. 2023 Jun 8;13(6):966. 
(free PDF)

Messner Z, Carro-Vazquez D, Haschka J, Grillari J, Resch H, Muschitz C, Pietschmann P, Zwerina J, Hackl M, Kocijan R (2022). Circulating miRNAs Respond to Denosumab Treatment after Two Years in Postmenopausal Women with Osteoporosis. J Clin Endocrinol Metab. 2022 Nov 19:dgac667. 

Schanda JE, Heher P, Weigl M, Drechsler S, Schädl B, Prueller J, Kocijan R, Heuberer PR, Hackl M, Muschitz C, Grillari J, Redl H, Feichtinger X, Fialka C, Mittermayr R (2022). Muscle-Specific Micro-Ribonucleic Acids miR-1-3p, miR-133a-3p, and miR-133b Reflect Muscle Regeneration After Single-Dose Zoledronic Acid Following Rotator Cuff Repair in a Rodent Chronic Defect Model. Am J Sports Med. 2022 Oct;50(12):3355-3367. 

Carro Vázquez D, Emini L, Rauner M, Hofbauer C, Grillari J, Diendorfer AB, Eastell R, Hofbauer LC, Hackl M (2022) Effect of Anti-Osteoporotic Treatments on Circulating and Bone MicroRNA Patterns in Osteopenic ZDF Rats. Int J Mol Sci. 2022 Jun 10;23(12):6534. 
(free PDF).

Muschitz C, Hummer M, Grillari J, Hlava A, Birnger AH, Hemetsberger M, Bimai HP (2022) Epidemiology and economic burden of fragility fractures in Austria. Osteoporos Int 2022. Mar;33(3):637-647. 
(free PDF)

Zupan J, Strazar K, Kocijan R, Nau T, Grillari J, Marolt Presen D (2021) Age-related alterations and senescence of mesenchymal stromal cells: Implications for regenerative treatments of bones and joints. Mech Ageing Dev 2021 Sep;198:111539. 

Vogt S, Bobbili MR, Stadlmayr G, Stadlbauer K, Kjems J, Rüker F, Grillari J, Wozniak-Knopp (2021). An engineered CD81-based combinatorial library for selecting recombinant binders to cell surface proteins: Laminin binding CD81 enhances cellular uptake of extracellular vesicles. J Extracell Vesicles. 2021 Sep;10(11):e12139.
(free PDF)

Pils V, Terlecki-Zaniewicz L, Schosserer M, Grillari J, Lämmermann I (2021) The role of lipid-based signalling in wound healing and senescence. Mech Ageing Dev2021 Sep;198:111527.

Kocijan R, Weigl M, Skalicky S, Geiger E, Ferguson J, Leinfellner G, Heimel P, Pietschmann P, Grillari J, Redl H, Hackl M (2020) MicroRNA levels in bone and blood change during bisphosphonate and teriparatide therapy in an animal model of postmenopausal osteoporosis. Bone. 2020 Feb;131:115104.

Hauser F, Naderer C, Priglinger E, Peterbauer A, Fischer MB, Redl H, Jacak J (2024). Single molecule studies of dynamic platelet interactions with endothelial cells. Front Bioeng Biotechnol. 2024 Apr 3;12:1372807. 
(free PDF)

Sivun D, Murtezi E, Karimian T, Hurab K, Marefat M, Klimareva E, Naderer C, Buchroithner B, Klar TA, Gvindzhiliia G, Horner A, Jacak J (2024). Multiphoton lithography with protein photoresists. Mater Today Bio. 2024 Feb 10;25:100994. 
(free PDF)

Sych T, Schlegel J, Barriga HMG, Ojansivu M, Hanke L, Weber F, Beklem Bostancioglu R, Ezzat K, Stangl H, Plochberger B, Laurencikiene J, El Andaloussi S, Fürth D, Stevens MM, Sezgin E. (2023). High-throughput measurement of the content and properties of nano-sized bioparticles with single-particle profiler. Nat Biotechnol. 2023 Jun 12. 

Puthukodan S, Hofmann M, Mairhofer M, Janout H, Schurr J, Hauser F, Naderer C, Preiner J, Winkler S, Sivun D, Jacak J (2023). Purification Analysis, Intracellular Tracking, and Colocalization of Extracellular Vesicles Using Atomic Force and 3D Single-Molecule Localization Microscopy. Anal Chem. 2023 Apr 11;95(14):6061-6070. 
(free PDF)

Strohmeier K, Hofmann M, Jacak J, Narzt MS, Wahlmueller M, Mairhofer M, Schaedl B, Holnthoner W, Barsch M, Sandhofer M, Wolbank S, Priglinger E. (2023). Multi-Level Analysis of Adipose Tissue Reveals the Relevance of Perivascular Subpopulations and an Increased Endothelial Permeability in Early-Stage Lipedema. Biomedicines. 2022 May 18;10(5):1163.
(free PDF)

Puthukodan S, Hofmann M, Mairhofer M, Janout H, Schurr J, Hauser F, Naderer C, Preiner J, Winkler S, Sivun D, Jacak J. (2023). Purification Analysis, Intracellular Tracking, and Colocalization of Extracellular Vesicles Using Atomic Force and 3D Single-Molecule Localization Microscopy. Anal Chem. 2023 Apr 11;95(14):6061-6070. 
(free PDF)

Strohmeier K, Hofmann M, Hauser F, Sivun D, Puthukodan S, Karner A, Sandner G, Le Renard PE, Jacak J, Mairhofer M (2021). CRISPR/Cas9 Genome Editing vs. Over-Expression for Fluorescent Extracellular Vesicle-Labeling: A Quantitative Analysis. Int J Mol Sci. 2021 Dec 28;23(1):282. 
(free PDF)

Priglinger E, Strasser J, Buchroithner B, Weber F, Wolbank S, Auer D, Grasmann E, Arzt C, Sivun D, Grillari J, Jacak J, Preiner J, Gimona M (2021). Label-free characterization of an extracellular vesicle-based therapeutic. J Extracell Vesicles. 2021 Oct;10(12):e12156.
(free PDF)

Crnic A, Rohringer S, Tyschuk T, Holnthoner W (2024). Engineering blood and lymphatic microvascular networks. Atherosclerosis. 2024 Jun;393:117458. 
(free PDF)

Pultar M, Oesterreicher J, Hartmann J, Weigl M, Diendorfer A, Schimek K, Schädl B, Heuser T, Brandstetter M, Grillari J, Sykacek P, Hackl M, Holnthoner W (2024). Analysis of extracellular vesicle microRNA profiles reveals distinct blood and lymphatic endothelial cell origins. J Extracell Biol. 2024 Jan 15;3(1):e134. 
(free PDF)

Hromada C, Hartmann J, Oesterreicher J, Stoiber A, Daerr A, Schädl B, Priglinger E, Teuschl-Woller AH, Holnthoner W, Heinzel J, Hercher D (2022). Occurrence of Lymphangiogenesis in Peripheral Nerve Autografts Contrasts Schwann Cell-Induced Apoptosis of Lymphatic Endothelial Cells In Vitro. Biomolecules. 2022 Jun 12;12(6):820. 
(free PDF).

Strohmeier K, Hofmann M, Jacak J, Narzt MS, Wahlmueller M, Mairhofer M, Schaedl B, Holnthoner W, Barsch M, Sandhofer M, Wolbank S, Priglinger E (2022). Multi-Level Analysis of Adipose Tissue Reveals the Relevance of Perivascular Subpopulations and an Increased Endothelial Permeability in Early-Stage Lipedema. Biomedicines. 2022 May 18;10(5):1163. 
(free PDF)

Trisko J, Fleck J, Kau S, Oesterreicher J, Holnthoner W (2022). Lymphatic and Blood Endothelial Extracellular Vesicles: A Story Yet to Be Written. Life (Basel). 2022 Apr 28;12(5):654. 
(free PDF)

Schneider J, Pultar M, Oesterreicher J, Bobbili MR, Mühleder S, Priglinger E, Redl H, Spittler A, Grillari J, Holnthoner W (2021) Cre mRNA Is Not Transferred by EVs from Endothelial and Adipose-Derived Stromal/Stem Cells during Vascular Network Formation. Int J Mol Sci 2021 Apr 14;22(8):4050
(free PDF)

Oesterreicher J, Pultar M, Schneider J, Mühleder S, Zipperle J, Grillari J, Holnthoner W (2021). Fluorescence-Based Nanoparticle Tracking Analysis and Flow Cytometry for Characterization of Endothelial Extracellular Vesicle Release. Int J Mol Sci. 2020 Dec 4;21(23):9278.
(free PDF)

Mühleder S, Fuchs C, Basílio J, Szwarc D, Pill K, Labuda K, Slezak P, Siehs C, Pröll J, Priglinger E, Hoffmann C, Junger WG, Redl H, Holnthoner W (2019). Purinergic P2Y2 receptors modulate endothelial sprouting. Cell Mol Life Sci. 2019 Jul 5.

Nürnberger S, Lindner C, Maier J, Strohmeier K, Wurzer C, Slezak P, Suessner S, Holnthoner W, Redl H, Wolbank S, Priglinger E (2019). Adipose-tissue-derived therapeutic cells in their natural environment as an autologous cell therapy strategy: the microtissue-stromal vascular fraction. Eur Cell Mater. 2019 Feb 22;37:113-133.

Pill K, Melke J, Mühleder S, Pultar M, Rohringer S, Priglinger E, Redl HR, Hofmann S, Holnthoner W (2018). Microvascular Networks From Endothelial Cells and Mesenchymal Stromal Cells From Adipose Tissue and Bone Marrow: A Comparison. Front Bioeng Biotechnol. 2018 Oct 25;6:156.
(free PDF)

Holnthoner W, Bonstingl C, Hromada C, Muehleder S, Zipperle J, Stojkovic S, Redl H, Wojta J, Schoechl H, Grillari J, Weilner S, Schlimp C. (2017). Endothelial Cell-derived Extracellular Vesicles Size-dependently Exert Procoagulant Activity Detected by Thromboelastometry. SciRep 25th April 2017 : 3707 (2017)
(free PDF)

Hromada C, Muehleder S, Grillari J, Redl H, Holnthoner W. (2017). Endothelial Extracellular Vesicles – Promises and Challenges. Front Physiol. 2016; doi: 10.3389/fphys.2017.00275
(free PDF)

Knezevic L, Schaupper M, Mühleder S, Schimek K, Hasenberg T, Marx U, Priglinger E, Redl H, Holnthoner W. (2017). Engineering Blood and Lymphatic Microvascular Networks in Fibrin Matrices. Front. Bioeng. Biotechnol. 5:25. doi: 10.3389/fbioe.2017.00025
(free PDF)

Schaupper MV, Jeltsch M, Rohringer S, Redl H, & Holnthoner W. (2016). Lymphatic vessels in Regenerative Medicine and Tissue Engineering. Tissue Eng Part B Rev, 22(5):395-407.

Schneider K, Aigner P, Monforte X, Nuernberger S, Holnthoner W, Ruenzler D, Redl H, & Teuschl AH. (2016). Decellularized human placenta chorion matrix as a favorable source of small diameter vascular grafts. Acta Biomaterialia, 29:125-34.

Pill K, Hofmann S, Redl H, & Holnthoner W. (2015). Vascularization mediated by mesenchymal stem cells from bone marrow and adipose tissue: a comparison. Cell Regen (Lond), 4:8.
(free PDF)